keyword
https://read.qxmd.com/read/38647971/a-circuitous-route-for-in-vitro-multi-enzyme-cascade-production-of-cytidine-triphosphate-to-overcome-the-thermodynamic-bottleneck
#1
JOURNAL ARTICLE
Zonglin Li, Yahui Zhong, Zhoulei Qing, Zhimin Li
Cytidine triphosphate (CTP), as a substance involved in the metabolism of phospholipids, proteins and nucleic acids, has precise drug effects and is a direct precursor for the synthesis of drugs such as citicoline. In this study, we established an in vitro six-enzyme cascade system to generate CTP. To avoid thermodynamic bottlenecks, we employed a circuitous and two-stage reaction strategy. Using cytidine as the key substrate, the final product CTP is obtained via the deamination and uridine phosphorylation pathways, relying on the irreversible reaction of cytidine triphosphate synthase to catalyze the amination of uridine triphosphate...
January 4, 2024: Bioresources and Bioprocessing
https://read.qxmd.com/read/38529864/-asthenic-disorders-correction-with-recognan
#2
JOURNAL ARTICLE
O A Shavlovskaya, I A Bokova
Asthenia, asthenic syndrome, asthenic condition, asthenic reaction, asthenic disorders are terms that describe the state of «impotence». Fatigue that occurs against the background of habitual physical or intellectual stress for a person, and persists after rest, is asthenia. For people of the older age group, the term senile asthenia syndrome is used. Asthenia manifests itself with increased fatigue and exhaustion, mood instability, increased irritability, sleep disorders. Asthenic conditions manifest themselves along with a decrease in physical activity, increased cognitive and mental fatigue...
2024: Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova
https://read.qxmd.com/read/38524067/neuroprotection-by-cerebrolysin-and-citicoline-through-the-upregulation-of-brain-derived-neurotrophic-factor-bdnf-expression-in-the-affected-neural-cells-a-preliminary-clue-obtained-through-an-in-vitro-study
#3
JOURNAL ARTICLE
Anandan P, Santhanam Rengarajan, Sankar Venkatachalam, Sasikumar Pattabi, Sumathi Jones, Prabhu K, Vani Krishna, Krishna Prasanth
OBJECTIVES: Citicoline and cerebrolysin are two unique yet contentious medications because of inconsistencies in efficacy as well as the mystery surrounding their mode of action. The current study aimed to re-validate the neuroprotective benefits of these medications and investigate the possible molecular mechanism. METHODS: Neuro-2A cells were exposed to tert-butyl hydroperoxide, a consistent in vitro model of neuronal damage caused by oxidative stress. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, acridine orange/ethidium bromide (AO-EtBr) staining, and phase-view examinations were utilized to evaluate cell survival and cytotoxicity...
February 2024: Curēus
https://read.qxmd.com/read/38432442/additive-anxiolytic-like-effect-of-citicoline-and-acpa-in-the-non-acute-restraint-stress-nars-and-acute-restraint-stress-ars-mice
#4
JOURNAL ARTICLE
Aysan Amnzade, Mohammad-Reza Zarrindast, Fatemeh Khakpai
The cannabinoid system plays a key role in stress-related emotional symptoms such as anxiety. Citicoline is a supplemental substance with neuroprotective properties that alleviates anxiety-related behaviors. There is a relation between the actions of cannabinoids and cholinergic systems. So, we decided to evaluate the effects of intracerebroventricular (i.c.v.) infusion of cannabinoid CB1 receptor agents on citicoline-produced response to anxiety-like behaviors in the non-acute restraint stress (NARS) and acute restraint stress (ARS) mice...
March 1, 2024: Physiology & Behavior
https://read.qxmd.com/read/38428646/synergistic-effects-of-citicoline-and-silymarin-nanomicelles-in-restraint-stress-exposed-mice
#5
JOURNAL ARTICLE
Elham Shayan, Fatemeh Maheri, Fatemeh Aflaki, Seyyedeh-Elaheh Mousavi, Mohammad-Reza Zarrindast, Nahid Fakhraei, Seyyed-Mahdi Rezayat Sorkhabadi, Seyed-Mohammad-Masoud Shushtarian
UNLABELLED: This study evaluated the effects of citicoline and silymarin nanomicelles (SMnm) in repeated restraint stress (RRS). METHOD: Mice were exposed to RRS for four consecutive days, 2 hrs. daily. On day 5 of the study, SMnm (25 and 50mg/kg, i.p.) and citicoline (25 and 75mg/kg), and a combination of them (25mg/kg, i.p.) were initiated. On day 18, anxiety-like behavior, behavioral despair, and exploratory behavior were evaluated. The prefrontal cortex (PFC) and the hippocampus were dissected measuring brain-derived neurotrophic factor (BDNF), cAMP response element-binding protein (CREB), and tumor necrosis factor-alpha (TNF-α) through Western Blot and ELISA, respectively...
February 28, 2024: Behavioural Brain Research
https://read.qxmd.com/read/38401462/the-emerging-role-of-%C3%AE-7nachrs-caspase-3-nrf-2-signaling-pathway-in-citicoline-improved-autistic-behavior-induced-by-thimerosal-in-mice
#6
JOURNAL ARTICLE
Nourhan A Khattab, Aya H El-Kadem, Samar S Elblehi, Nageh Ahmed El-Mahdy, Nagla A El-Shitany
AIMS: Autism spectrum disorder (ASD) is a global concern,affecting around 75 million individuals.Various factors contribute to ASD,including mercury-containing preservatives like thimerosal (Thim) found in some vaccines.This study explored whether citicoline could be a therapeutic option for Thim-induced neuronal damage in a mouse model of ASD.Additionally,the study investigated the effects of citicoline on the α7nAChRs/Akt/Nrf2/caspase-3 pathway,which may be involved in the development of ASD...
February 23, 2024: International Immunopharmacology
https://read.qxmd.com/read/38400742/repurposing-fda-approved-drugs-as-nlrp3-inhibitors-against-inflammatory-diseases-machine-learning-and-molecular-simulation-approaches
#7
JOURNAL ARTICLE
Vipul Agarwal, Rajesh Haldhar, Abdurahman Hajinur Hirad, Bilal Ahmed, Sang Beom Han, Anugya Gupta, Vinit Raj, Sangkil Lee
Activation of NLRP3 (NOD-like receptor family, pyrin domain-containing protein 3) has been associated with multiple chronic pathologies, including diabetes, atherosclerosis, and rheumatoid arthritis. Moreover, histone deacetylases (HDACs), specifically HDAC6 is required for the NLRP3 inflammasome to assemble and activate. Thus, NLRP3 serves as an attractive target for the development of novel therapeutic approaches. Several companies are now attempting to develop specific modulators of the NLRP3 inflammasome, but only a handful of small molecules of NLRP3 inflammasome inhibitors, such as MCC950 and Tranilast, are currently available for clinical use...
February 24, 2024: Journal of Biomolecular Structure & Dynamics
https://read.qxmd.com/read/38383902/synergistic-antidepressant-like-effect-of-citicoline-and-cb-1-agonist-in-male-mice
#8
JOURNAL ARTICLE
Aysan Amanzade, Fatemeh Khakpai, Mohammad-Reza Zarrindast
BACKGROUND: The endocannabinoid system plays a key role in the control of many emotional-correlated reactions such as stress, depressed mood, and anxiety. Moreover, citicoline has neuroprotective properties and indicates beneficial effects in the treatment of depressive problems. Acute restraint stress (ARS) is an experimental model used for the induction of rodent models of depression. OBJECTIVE: This research was designed to assess the effects of intracerebroventricular (i...
February 21, 2024: Psychopharmacology
https://read.qxmd.com/read/38260297/nutraceuticals-and-phytoceuticals-in-the-treatment-of-schizophrenia-a-systematic-review-and-network-meta-analysis
#9
Michele Fornaro, Claudio Caiazza, Martina Billeci, Michael Berk, Wolfgang Marx, Vicent Balanzá-Martínez, Michele De Prisco, Rosanna Pezone, Giuseppe De Simone, Niccolo' Solini, Felice Iasevoli, Fabrice Berna, Guillaume Fond, Laurent Boyer, Andre F Carvalho, Elena Dragioti, Jess Fiedorowicz, Andrea de Bartolomeis, Christoph Correll, Marco Solmi
Background : Sub-optimal response in schizophrenia is frequent, warranting augmentation strategies over treatment-as-usual (TAU). Methods : We assessed nutraceuticals/phytoceutical augmentation strategies via network meta-analysis. Randomized controlled trials in schizophrenia/schizoaffective disorder were identified via the following databases: PubMed, MEDLINE, EMBASE, Scopus, PsycINFO, CENTRAL, and ClinicalTrials.gov. Change (Standardized Mean Difference=SMD) in total symptomatology and acceptability (Risk Ratio=RR) were co-primary outcomes...
January 12, 2024: Research Square
https://read.qxmd.com/read/38136170/memory-recovery-effect-of-a-new-bioactive-innovative-combination-in-rats-with-experimental-dementia
#10
JOURNAL ARTICLE
Lyubka Tancheva, Reni Kalfin, Borislav Minchev, Diamara Uzunova, Krasimira Tasheva, Elina Tsvetanova, Almira Georgieva, Albena Alexandrova, Miroslava Stefanova, Ayten Solak, Maria Lazarova, Yordan Hodzhev, Valya Grigorova, Dobri Yarkov, Polina Petkova-Kirova
Alzheimer's disease manifests as a complex pathological condition, with neuroinflammation, oxidative stress and cholinergic dysfunction being a few of the many pathological changes. Due to the complexity of the disease, current therapeutic strategies aim at a multitargeted approach, often relying on a combination of substances with versatile and complementary effects. In the present study, a unique combination of α-lipoic acid, citicoline, extracts of leaves from olive tree and green tea, vitamin D3, selenium and an immune-supporting complex was tested in scopolamine-induced dementia in rats...
November 28, 2023: Antioxidants (Basel, Switzerland)
https://read.qxmd.com/read/38069187/liposomal-encapsulation-of-citicoline-for-ocular-drug-delivery
#11
JOURNAL ARTICLE
Claudia Bonechi, Fariba Fahmideh Mahdizadeh, Luigi Talarico, Simone Pepi, Gabriella Tamasi, Gemma Leone, Marco Consumi, Alessandro Donati, Agnese Magnani
Glaucoma represents a group of neurodegenerative diseases characterized by optic nerve damage and the slowly progressive death of retinal ganglion cells. Glaucoma is considered the second leading cause of irreversible blindness worldwide. Pharmaceutical treatment of glaucoma is critical because of the properties of the ocular barrier that limit the penetration of drugs, resulting in lower systemic bioavailability. This behavior causes the need of frequent drug administration, which leads to deposition of concentrated solutions on the eye, causing toxic effects and cellular damage to the eye...
November 28, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/37994884/-recognan-citicoline-efficacy-and-safety-in-cognitive-impairment-correction-of-various-nosological-forms
#12
JOURNAL ARTICLE
O A Shavlovskaya, I A Bokova
Insufficiency of a choline derivative (acetylcholine) can lead to the development of cognitive impairment (CI). One of the most well-known and well-studied medical drugs (MD) containing choline and having neuroprotective properties is citicoline (Recognan). A number of studies have demonstrated the effectiveness of Recognan in relation to mild CI, chronic cerebrovascular diseases (CVD), acute vascular disorders (including post-traumatic genesis). Recognan improves memory and other cognitive functions in healthy young people against the background of asthenia due to stress or increased cognitive and emotional stress or infection, and also has a preventive effect on fading cognitive functions in the process of age-related changes...
2023: Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova
https://read.qxmd.com/read/37991949/effect-of-investigational-combinations-of-neuroprotectants-on-the-level-of-s-100-and-nse-protein-in-the-blood-serum-of-patients-with-moderate-and-severe-ischemic-stroke
#13
JOURNAL ARTICLE
R Karimulin, A Semenenko
Ischemic cerebral stroke (ICS) is a devastating neurological pathology associated with enormous comorbidity and mortality. Preliminary experimental screening of cerebroprotective agents with different mechanisms of action was performed: Edaravone, Cerebrolysin, Choline alfoscerate, Citicoline, Mexidol, the most effective combinations of cerebroprotectors were identified, followed by their screening for efficacy in clinical conditions by neuron-specific enolase (NSE) and S100 protein, as one of the main biochemical markers of brain damage in acute ischemic stroke...
September 2023: Georgian Medical News
https://read.qxmd.com/read/37827341/cdp-choline-modulates-cholinergic-signaling-and-gut-microbiota-to-alleviate-dss-induced-inflammatory-bowel-disease
#14
JOURNAL ARTICLE
Lingnan Guo, Qiang Chen, Yiyuan Gao, Hao Jiang, Feini Zhou, Fan Zhang, Maosheng Xu
Inflammatory bowel diseases (IBD) represent chronic gastrointestinal inflammatory disorders characterized by a complex and underexplored pathogenic mechanism. Previous research has revealed that IBD patients often have a deficiency of choline and its metabolites, including acetylcholine (ACh) and phosphatidylcholine (PC), within the colon. However, a comprehensive study linking these three substances and their mechanistic implications in IBD remains lacking. This study aimed to investigate the efficacy and underlying mechanism of cytidine diphosphate (CDP)-choline (citicoline), an intermediate product of choline metabolism, in a mouse model of IBD induced by dextran sulfate sodium salt (DSS)...
October 10, 2023: Biochemical Pharmacology
https://read.qxmd.com/read/37812361/the-combination-of-citicoline-and-nicotinamide-mononucleotide-induces-neurite-outgrowth-and-mitigates-vascular-cognitive-impairment-via-sirt1-creb-pathway
#15
JOURNAL ARTICLE
Ning Zhao, Xiaofeng Zhu, Luyang Xie, Xin Guan, Leilei Tang, Guojun Jiang, Tao Pang
Vascular dementia (VD) is characterized with vascular cognitive impairment (VCI), which currently has few effective therapies in clinic. Neuronal damage and white matter injury are involved in the pathogenesis of VCI. Citicoline has been demonstrated to exhibit neuroprotection and neurorepair to improve cognition in cerebrovascular diseases. Nicotinamide adenine dinucleotide (NAD+ )-dependent sirtuin (SIRT) signaling pathway constitutes a strong intrinsic defense system against various stresses including neuroinflammation in VCI...
November 2023: Cellular and Molecular Neurobiology
https://read.qxmd.com/read/37768938/efficacy-of-citicoline-as-a-supplement-in-glaucoma-patients-a-systematic-review
#16
JOURNAL ARTICLE
Julia Prinz, Verena Prokosch, Hanhan Liu, Peter Walter, Matthias Fuest, Filippo Migliorini
PURPOSE: Glaucoma is a leading cause of irreversible blindness worldwide. Retinal ganglion cells (RGC), the neurons that connect the eyes to the brain, specifically die in glaucoma, leading to blindness. Elevated intraocular pressure (IOP) is the only modifiable risk factor, however, many patients progress despite excellent IOP control. Thus, alternative treatment strategies to prevent glaucoma progression are an unmet need. Citicoline has demonstrated neuroprotective properties in central neurodegenerative diseases...
2023: PloS One
https://read.qxmd.com/read/37759876/persistent-cognitive-dysfunction-in-a-non-hospitalized-covid-19-long-hauler-patient-responding-to-cognitive-rehabilitation-and-citicoline-treatment
#17
Roberto Monastero, Roberta Baschi
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is characterized by severe flu-like symptoms, which can progress to life-threatening systemic inflammation and multiorgan dysfunction. The nervous system is involved in over one-third of patients, and the most common neurological manifestations concern the central nervous system, such as headache, fatigue, and brain fog. The activation of innate, humoral, and cellular immune responses, resulting in a cytokine storm and endothelial and mitochondrial dysfunctions, are the main pathophysiological mechanisms of SARS-CoV-2 infection...
September 1, 2023: Brain Sciences
https://read.qxmd.com/read/37756375/response-to-folweiler-ka-et-al-unsupervised-machine-learning-reveals-novel-traumatic-brain-injury-patient-phenotypes-with-distinct-acute-injury-profiles-and-long-term-outcomes-doi-10-1089-neu-2019-6705
#18
LETTER
https://read.qxmd.com/read/37737074/citicoline-on-the-barthel-index-severe-and-moderate-brain-injury
#19
JOURNAL ARTICLE
Mehdi Mahmoodkhani, Bahram Aminmansour, Mehdi Shafiei, Mohammadreza Hasas, Donya Sheibani Tehrani
INTRODUCTION: Traumatic brain injury (TBI) is a paramount factor in mortality and morbidity. The clinical trials conducted to investigate the efficacy of neuroprotective agents, such as citicoline, as a therapeutic alternative for TBI have presented divergent findings. Therefore, this study aimed to evaluate and compare citicoline's effect on the Barthel Index in patients with severe and moderate brain injury. MATERIALS AND METHODS: The study is a randomized clinical trial...
2023: Indian Journal of Pharmacology
https://read.qxmd.com/read/37731716/restored-retinal-physiology-after-administration-of-niacin-with-citicoline-in-a-mouse-model-of-hypertensive-glaucoma
#20
JOURNAL ARTICLE
Alberto Melecchi, Rosario Amato, Massimo Dal Monte, Dario Rusciano, Paola Bagnoli, Maurizio Cammalleri
INTRODUCTION: Much interest has been addressed to antioxidant dietary supplements that are known to lower the risk of developing glaucoma or delay its progression. Among them, niacin and citicoline protect retinal ganglion cells (RGCs) from degeneration by targeting mitochondria, though at different levels. A well-established mouse model of RGC degeneration induced by experimental intraocular pressure (IOP) elevation was used to investigate whether a novel combination of niacin/citicoline has better efficacy over each single component in preserving RGC health in response to IOP increase...
2023: Frontiers in Medicine
keyword
keyword
3954
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.